{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:05:51Z","timestamp":1789430751937,"version":"build-2803163510"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.radonc.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T16:00:43Z","timestamp":1479916843000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update \u2013 Improvement by cross sectional imaging based treatment planning and stepping source technology"],"prefix":"10.1016","volume":"122","author":[{"given":"Gy\u00f6rgy","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Martinez-Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Budrukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Guinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratislav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Skowronek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank-Andr\u00e9","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.10.008_b0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely originate from regions with high baseline 18F-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-007-1663-8","article-title":"Locoregional failure analysis in head-and-neck cancer patients treated with IMRT","volume":"183","author":"Studer","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-010-2130-5","article-title":"Pattern of failure after helical tomotherapy in head and neck cancer","author":"Farragh","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0167-8140(93)90021-Y","article-title":"Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth","volume":"26","author":"Simon","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0030","series-title":"Modern brachytherapy","author":"Pierquin","year":"1987"},{"key":"10.1016\/j.radonc.2016.10.008_b0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-8140(00)00324-8","article-title":"How to use the paris system in the year 2001?","volume":"58","author":"Hennequin","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2006.04.013","article-title":"A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58","volume":"79","author":"Siebert","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0045","series-title":"Practical handbook of brachytherapy","first-page":"166","article-title":"ENT Tumors","author":"Strnad","year":"2014"},{"key":"10.1016\/j.radonc.2016.10.008_b0050","series-title":"Dose and volume specification for reporting interstitial therapy","author":"ICRU 58","year":"1997"},{"key":"10.1016\/j.radonc.2016.10.008_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0360-3016(91)90158-Z","article-title":"Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy","volume":"20","author":"Brenner","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0360-3016(95)02054-3","article-title":"Pulsed dose rate and fractionated high dose rate brachytherapy: Choice of brachytherapy schedules to replace low dose rate treatments","volume":"34","author":"Visser","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.brachy.2014.05.011","article-title":"A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy","volume":"13","author":"Haddad","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5114\/jcb.2011.23199","article-title":"Long term results of pdr brachytherapy for lip cancer","volume":"3","author":"Johansson","year":"2011","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.radonc.2016.10.008_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5114\/jcb.2011.21037","article-title":"Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long term results from a uniform clinacal series. Journal of Contemporary","volume":"3","author":"Johansson","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.brachy.2013.07.002","article-title":"Interstitial pulsed-dose-rate brachytherapy for head and neck cancer \u2013 single institution long-term results of 385 patients","volume":"12","author":"Strnad","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0085","doi-asserted-by":"crossref","first-page":"e65423","DOI":"10.1371\/journal.pone.0065423","article-title":"High dose rate versus low dose rate brachytherapy for oral cancer\u2013a meta-analysis of clinical trials","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2016.10.008_b0090","first-page":"404","article-title":"Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy","volume":"6","author":"Kovacs","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canrad.2013.01.007","article-title":"Curieth\u00e9rapie des cancers des voies a\u00e9rodigestives sup\u00e9rieures","volume":"17","author":"Lapeyre","year":"2013","journal-title":"Cancer Radiotherapie"},{"key":"10.1016\/j.radonc.2016.10.008_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2007.07.009","article-title":"Dysphagia disorders in patients with cancer of the oropharynx","volume":"85","author":"Levendag","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2007.06.004","article-title":"Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: correlation with dose and volume parameters","volume":"85","author":"Jensen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2009.02.017","article-title":"Dosimetric factors associated with long-term dysphagia after definitive radiotherapy","volume":"76","author":"Caudell","year":"2010","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0120","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1118\/1.4747264","article-title":"Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation","volume":"39","author":"Beaulieu","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5114\/jcb.2013.39444","article-title":"Head and neck 192Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver","volume":"5","author":"Siebert","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0130","first-page":"2183","article-title":"Treatment of epidermoid epithelioma of the lip. 2363 cases","author":"Mazeron","year":"1983","journal-title":"Presse Med"},{"issue":"21\u20134","key":"10.1016\/j.radonc.2016.10.008_b0135","first-page":"17","article-title":"Treatment of the carcinoma of the lip through high dose rate brachytherapy","volume":"10","author":"Finestres","year":"2005","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.radonc.2016.10.008_b0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-8140(95)01685-6","article-title":"Quality assurance of interstitial brachytherapy in lip cancer: comparison of actual performance with the Paris system recommendations","volume":"32","author":"Farrus","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0145","series-title":"Long term outcome research on PDR brachytherapy with focus on breast, base of tongue, and lip cancer","author":"Johansson","year":"2010"},{"key":"10.1016\/j.radonc.2016.10.008_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-8140(03)00271-8","article-title":"Lip cancer treatment with high dose rate therapy","volume":"69","author":"Guinot","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.brachy.2013.05.007","article-title":"From low dose rate to high dose rate brachytherapy in lip carcinoma: equivalent results with fewer complications","volume":"12","author":"Guinot","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.09.038","article-title":"High-dose-rate versus low-dose rate brachytherapy for lip cancer","volume":"83","author":"Ghadjar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0165","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hed.23529","article-title":"Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy","volume":"36","author":"Guinot","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.10.008_b0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brachy.2009.10.003","article-title":"Efficacy of high dose-rate interstitial brachytherapy in patients with oral tongue carcinoma","volume":"9","author":"Guinot","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0175","doi-asserted-by":"crossref","unstructured":"Tuceka L, Peterab J, Sir\u00e1kb I, et al. Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer Reports of practical oncology and radiotherapy. 2011;16:243\u2013247.","DOI":"10.1016\/j.rpor.2011.07.001"},{"key":"10.1016\/j.radonc.2016.10.008_b0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0167-8140(98)00076-0","article-title":"Simplified non-looping functional loop technique for hdr brachytherapy","volume":"48","author":"Nag","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0185","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0360-3016(90)90299-Y","article-title":"Primary radiotherapy in the treatment of stage I and II oral tongue cancers: Importance of the proportion of therapy delivered with interstitial therapy","volume":"18","author":"Wendt","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0360-3016(01)01561-9","article-title":"Phase III trial of high vs. LDR interstitial radiotherapy for mobile tongue cancer","volume":"51","author":"Ta","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0360-3016(98)00041-8","article-title":"High dose rate versus LDR interstitial radiotherapy for carcinoma of the floor of mouth","volume":"41","author":"Ta","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-8140(00)00294-2","article-title":"Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group","volume":"58","author":"Peiffert","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0205","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/hed.23244","article-title":"Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer","volume":"35","author":"Al-Mamgani","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.10.008_b0210","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/00005537-199912000-00013","article-title":"High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx","volume":"109","author":"Rudoltz","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.10.008_b0215","first-page":"983","article-title":"High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients","volume":"59","author":"Nose","year":"2004","journal-title":"Int J RadiatOncolBiol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brachy.2004.02.001","article-title":"Brachytherapy in the treatment of Stage IV carcinoma of the base of tongue","volume":"3","author":"Cano","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0225","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00066-004-1238-x","article-title":"Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma","volume":"180","author":"Tak\u00e1csi-Nagy","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-8140(02)00008-7","article-title":"High-dose, high precision treatment options for boosting cancer of the nasopharynx","volume":"63","author":"Levendag","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brachy.2012.06.001","article-title":"Local control in advanced cancer of the nasopharynx: is a boost dose by endocavitary brachytherapy of prognostic significance?","volume":"12","author":"Levendag","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0240","doi-asserted-by":"crossref","first-page":"e90048","DOI":"10.1371\/journal.pone.0090048","article-title":"Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma","volume":"9","author":"Wan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2016.10.008_b0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2014.11.012","article-title":"Endoscopy guided brachytherapy for sinonasal and nasopharyngeal recurrences","volume":"14","author":"Tagliaferri","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0958-3947(93)90026-P","article-title":"An afterloading 192-Ir surface mold","volume":"18","author":"Rustgi","year":"1993","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2016.10.008_b0255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/02841869609109923","article-title":"The efficacy of gold-198 grain mold therapy for mucosal carcinomas of the oral cavity","volume":"35","author":"Takeda","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2010.03.027","article-title":"The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review","volume":"65","author":"Alam","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.radonc.2016.10.008_b0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0360-3016(99)00547-7","article-title":"Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds","volume":"47","author":"Guix","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brachy.2010.08.005","article-title":"Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds","volume":"10","author":"Maronas","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0167-8140(98)00059-0","article-title":"Fractionated high dose rate brachytherapy moulds \u2013 a precise treatment for carcinoma of the pinna","volume":"48","author":"Allan","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0280","series-title":"Custom made mold brachytherapy, basal cell carcinoma","author":"Ersu","year":"2012"},{"key":"10.1016\/j.radonc.2016.10.008_b0285","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0360-3016(01)01567-X","article-title":"The American Brachytherapy Society recommendations for High-Dose-Rate brachytherapy for Head-And-Neck carcinoma","volume":"50","author":"Nag","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0290","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0360-3016(94)00485-4","article-title":"High dose-rate microselectron moulds in the treatment of skin tumours","volume":"31","author":"Svoboda","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13014-015-0390-z","article-title":"High dose rate brachytherapy using molds for lip and oral cavity tumors","volume":"10","author":"Unetsubo","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0300","first-page":"170","article-title":"The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators","volume":"175","author":"Kohler-Brock","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brachy.2014.08.050","article-title":"High-dose-rate brachytherapy in early oral cancer with close or positive margins","volume":"14","author":"Petera","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0748-7983(97)92484-7","article-title":"Post-operative brachytherapy: a prognostic factor for local control in epidermoid carcinomas of the mouth floor","volume":"23","author":"Lapeyre","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0360-3016(00)00538-1","article-title":"Postoperative brachytherapy alone for t1\u20132 n0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins","volume":"48","author":"Lapeyre","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0320","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hed.10377","article-title":"Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins","volume":"26","author":"Lapeyre","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.10.008_b0325","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/PL00002416","article-title":"Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997","volume":"177","author":"Grabenbauer","year":"2001","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0330","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hed.23007","article-title":"Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer","volume":"35","author":"Scala","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.10.008_b0335","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brachy.2013.01.165","article-title":"High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer","volume":"12","author":"Teckie","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2006.12.001","article-title":"High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers\u2013preliminary results","volume":"6","author":"Narayana","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcms.2007.08.009","article-title":"Combination of surgical resection and hdr-brachytherapy in patients with recurrent or advanced head and neck carcinomas","volume":"36","author":"Schiefke","year":"2008","journal-title":"J Cranio-maxillo-facial Surg"},{"key":"10.1016\/j.radonc.2016.10.008_b0350","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijrobp.2011.03.026","article-title":"Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (phdrb)","volume":"81","author":"Martinez-Monge","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radonc.2006.06.012","article-title":"Manually after-loaded 192ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer","volume":"80","author":"Nutting","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0360","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/cncr.22648","article-title":"The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers","volume":"109","author":"Kupferman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.10.008_b0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00066-010-2139-9","article-title":"Outcome after re-irradiation of head and neck cancer patients","volume":"187","author":"Platteaux","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-1-27","article-title":"Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy","volume":"1","author":"Pellizzon","year":"2006","journal-title":"Radiat oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00066-005-1424-5","article-title":"Role of interstitial pdr brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients","volume":"181","author":"Strnad","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jrr\/rrs103","article-title":"High dose rate brachytherapy for oral cancer","volume":"54","author":"Yamazaki","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2016.10.008_b0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1278-3218(97)84058-9","article-title":"Reirradiation hyperfractionnee apres chirurgie de rattrapage de carcinomes cervicaux faciaux. Resultat d\u00fane etude pilote de 14 patients","volume":"1","author":"Benchalal","year":"1997","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2016.10.008_b0390","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/00005537-200208000-00008","article-title":"High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer","volume":"112","author":"Glatzel","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2016.10.008_b0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0924-4212(96)80046-6","article-title":"Curietherapie de rattrapage des Cancers ORL (cavite buccale, oropharynx, cavum)","volume":"82","author":"Ardiet","year":"1997","journal-title":"Bull Cancer Radiother"},{"key":"10.1016\/j.radonc.2016.10.008_b0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2002-23115","article-title":"Brachytherapy with 192 Iridium in the treatment of recurrent nasopharyngeal carcinoma","volume":"81","author":"Fischer","year":"2002","journal-title":"Laryngorhinootologie"},{"key":"10.1016\/j.radonc.2016.10.008_b0405","first-page":"2695","article-title":"Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer","volume":"19","author":"Krull","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2016.10.008_b0410","first-page":"56","article-title":"Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences","volume":"43","author":"Nag","year":"1999","journal-title":"Rev Med Univ Navarra"},{"key":"10.1016\/j.radonc.2016.10.008_b0415","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0360-3016(01)01637-6","article-title":"Interstitial low dose rate brachytherapy as a salvage treatment for recurrent head and neck cancers. long term results","volume":"51","author":"Puthawala","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0420","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brachy.2008.12.007","article-title":"Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy","volume":"8","author":"Grimand","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0425","first-page":"327","article-title":"Brachytherapiy in the retreatment of patients with new primary head and neck cancer","volume":"36","author":"Grimand","year":"2007","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.radonc.2016.10.008_b0430","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/cncr.22648","article-title":"The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancer with curative intent","volume":"109","author":"Kupferman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.10.008_b0435","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0360-3016(94)90555-X","article-title":"High-dose reirradiation of head and neck cancer with curative intent","volume":"29","author":"Stevens","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2010.10.025","article-title":"Hypofractionated accelerated CT-guided interstitial 192-Ir HDR brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer","volume":"98","author":"Tselis","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brachy.2011.09.006","article-title":"High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head-and-neck cancers","volume":"11","author":"Bartochowska","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0450","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.brachy.2015.07.003","article-title":"Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?","volume":"14","author":"Bartochowska","year":"2015","journal-title":"Brachytherapy."},{"key":"10.1016\/j.radonc.2016.10.008_b0455","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00066-009-2012-x","article-title":"Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children","volume":"185","author":"Strege","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0460","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00066-005-1274-1","article-title":"Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced\/recurrent malignancies involving the skull base","volume":"181","author":"Strege","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.10.008_b0465","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0360-3016(87)90031-9","article-title":"Salvage radiation of oropharyngeal cancers using Ir-192 wire implants: 5 years results of 70 cases","volume":"13","author":"Mazeron","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0470","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0360-3016(94)90554-1","article-title":"Salvage irradiation by brachytherapy of velotonsillarsquamous cell carcinoma in a previously irradiated field: results in 73 cases","volume":"29","author":"Peiffert","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-8140(92)90026-Q","article-title":"Reirradiation by interstitial brachytherapy alone of cancers of the oropharynx in previously irradiated areas","volume":"25","author":"Peiffer","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0480","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0360-3016(97)00219-8","article-title":"Salvage brachytherapy of posterior pharyngeal wall squamous cell carcinoma in a previously treated area","volume":"38","author":"Pommier","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.008_b0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brachy.2013.10.008","article-title":"Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma","volume":"13","author":"Strnad","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2016.10.008_b0490","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00066-014-0809-8","article-title":"Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: long-term results","volume":"191","author":"Strnad","year":"2015","journal-title":"Strahlenther Oncol"},{"key":"10.1016\/j.radonc.2016.10.008_b0495","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13014-016-0583-0","article-title":"Second-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol","volume":"11","author":"Ritter","year":"2016","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T22:16:31Z","timestamp":1568585791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016343468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0167814016343468"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.10.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update \u2013 Improvement by cross sectional imaging based treatment planning and stepping source technology","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}